Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 397

1.

Reducing the socioeconomic gradient in uptake of the NHS bowel cancer screening Programme using a simplified supplementary information leaflet: a cluster-randomised trial.

Smith SG, Wardle J, Atkin W, Raine R, McGregor LM, Vart G, Morris S, Duffy SW, Moss S, Hackshaw A, Halloran S, Kralj-Hans I, Howe R, Snowball J, Handley G, Logan RF, Rainbow S, Smith S, Thomas M, Counsell N, von Wagner C.

BMC Cancer. 2017 Aug 14;17(1):543. doi: 10.1186/s12885-017-3512-1.

PMID:
28806955
2.

Colorectal adenomas, surveillance, and cancer - Authors' reply.

Atkin W, Wooldrage K, Sasieni P, Duffy SW, Cross AJ.

Lancet Oncol. 2017 Aug;18(8):e428. doi: 10.1016/S1470-2045(17)30532-6. Epub 2017 Jul 26. No abstract available.

PMID:
28759375
3.

The impact of trained radiographers as concurrent readers on performance and reading time of experienced radiologists in the UK Lung Cancer Screening (UKLS) trial.

Nair A, Screaton NJ, Holemans JA, Jones D, Clements L, Barton B, Gartland N, Duffy SW, Baldwin DR, Field JK, Hansell DM, Devaraj A.

Eur Radiol. 2017 Jun 22. doi: 10.1007/s00330-017-4903-z. [Epub ahead of print]

PMID:
28643093
4.

The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluations.

Atkin W, Brenner A, Martin J, Wooldrage K, Shah U, Lucas F, Greliak P, Pack K, Kralj-Hans I, Thomson A, Perera S, Wood J, Miles A, Wardle J, Kearns B, Tappenden P, Myles J, Veitch A, Duffy SW.

Health Technol Assess. 2017 Apr;21(25):1-536. doi: 10.3310/hta21250.

5.

Screening organization and recall rate in a regional breast screening programme.

Beruchashwili T, Gvamichava R, Duffy SW.

J Med Screen. 2017 Jan 1:969141317704680. doi: 10.1177/0969141317704680. [Epub ahead of print]

PMID:
28614990
6.

GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project.

Benton SC, Butler P, Allen K, Chesters M, Rickard S, Stanley S, Roope R, Vulkan D, Duffy SW.

Br J Cancer. 2017 Jun 6;116(12):1551-1557. doi: 10.1038/bjc.2017.129. Epub 2017 May 18.

7.

Effect of second timed appointments for non-attenders of breast cancer screening in England: a randomised controlled trial.

Allgood PC, Maroni R, Hudson S, Offman J, Turnbull AE, Peacock L, Steel J, Kirby G, Ingram CE, Somers J, Fuller C, Threlfall AG, Gabe R, Maxwell AJ, Patnick J, Duffy SW.

Lancet Oncol. 2017 Jul;18(7):972-980. doi: 10.1016/S1470-2045(17)30340-6. Epub 2017 May 15.

8.

Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study.

Atkin W, Wooldrage K, Brenner A, Martin J, Shah U, Perera S, Lucas F, Brown JP, Kralj-Hans I, Greliak P, Pack K, Wood J, Thomson A, Veitch A, Duffy SW, Cross AJ.

Lancet Oncol. 2017 Jun;18(6):823-834. doi: 10.1016/S1470-2045(17)30187-0. Epub 2017 Apr 28.

9.

Does Reader Performance with Digital Breast Tomosynthesis Vary according to Experience with Two-dimensional Mammography?

Tucker L, Gilbert FJ, Astley SM, Dibden A, Seth A, Morel J, Bundred S, Litherland J, Klassen H, Lip G, Purushothaman H, Dobson HM, McClure L, Skippage P, Stoner K, Kissin C, Beetles U, Lim YY, Hurley E, Goligher J, Rahim R, Gagliardi TJ, Suaris T, Duffy SW.

Radiology. 2017 May;283(2):371-380. doi: 10.1148/radiol.2017151936. Epub 2017 Mar 13.

PMID:
28287917
10.

Both a stage shift and changes in stage-specific survival have contributed to reductions in breast cancer mortality.

Duffy SW, Etzioni R, Sasieni P.

Evid Based Med. 2017 Apr;22(2):76. doi: 10.1136/ebmed-2016-110632. Epub 2017 Feb 22. No abstract available.

PMID:
28228386
11.

Initiators and promoters for the occurrence of screen-detected breast cancer and the progression to clinically-detected interval breast cancer.

Yen AM, Wu WY, Tabar L, Duffy SW, Smith RA, Chen HH.

J Epidemiol. 2017 Mar;27(3):98-106. doi: 10.1016/j.je.2016.10.003. Epub 2016 Nov 28.

12.

Breast-Cancer Tumor Size and Screening Effectiveness.

Brentnall AR, Duffy SW, Cuzick J.

N Engl J Med. 2017 Jan 5;376(1):94. doi: 10.1056/NEJMc1614282. No abstract available.

PMID:
28052231
13.

Optimum low dose CT screening interval for lung cancer: the answer from NELSON?

Baldwin DR, Duffy SW, Devaraj A, Field JK.

Thorax. 2017 Jan;72(1):6-7. doi: 10.1136/thoraxjnl-2016-209011. Epub 2016 Oct 21. No abstract available.

PMID:
27974632
14.

A national cluster-randomised controlled trial to examine the effect of enhanced reminders on the socioeconomic gradient in uptake in bowel cancer screening.

Raine R, Moss SM, von Wagner C, Atkin W, Hans IK, Howe R, Solmi F, Morris S, Counsell N, Hackshaw A, Halloran S, Handley G, Logan RF, Rainbow S, Smith S, Snowball J, Seaman H, Thomas M, Smith SG, McGregor LM, Vart G, Wardle J, Duffy SW.

Br J Cancer. 2016 Dec 6;115(12):1479-1486. doi: 10.1038/bjc.2016.365. Epub 2016 Nov 22.

PMID:
27875518
15.

Rapid review of evaluation of interventions to improve participation in cancer screening services.

Duffy SW, Myles JP, Maroni R, Mohammad A.

J Med Screen. 2017 Sep;24(3):127-145. doi: 10.1177/0969141316664757. Epub 2016 Oct 17.

16.

Implementation planning for lung cancer screening: five major challenges.

Field JK, Duffy SW, Devaraj A, Baldwin DR.

Lancet Respir Med. 2016 Sep;4(9):685-687. doi: 10.1016/S2213-2600(16)30233-8. No abstract available.

PMID:
27599242
17.

Is cancer survival associated with cancer symptom awareness and barriers to seeking medical help in England? An ecological study.

Niksic M, Rachet B, Duffy SW, Quaresma M, Møller H, Forbes LJ.

Br J Cancer. 2016 Sep 27;115(7):876-86. doi: 10.1038/bjc.2016.246. Epub 2016 Aug 18.

18.

Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial.

Brain K, Lifford KJ, Carter B, Burke O, McRonald F, Devaraj A, Hansell DM, Baldwin D, Duffy SW, Field JK.

Thorax. 2016 Nov;71(11):996-1005. doi: 10.1136/thoraxjnl-2016-208283. Epub 2016 Jul 28.

19.

Comparing the performance of trained radiographers against experienced radiologists in the UK lung cancer screening (UKLS) trial.

Nair A, Gartland N, Barton B, Jones D, Clements L, Screaton NJ, Holemans JA, Duffy SW, Field JK, Baldwin DR, Hansell DM, Devaraj A.

Br J Radiol. 2016 Oct;89(1066):20160301. doi: 10.1259/bjr.20160301. Epub 2016 Jul 27.

PMID:
27461068
20.

Ovarian cancer screening: UKCTOCS trial.

Sasieni PD, Duffy SW, Cuzick J.

Lancet. 2016 Jun 25;387(10038):2602. doi: 10.1016/S0140-6736(16)30847-9. No abstract available.

PMID:
27353820

Supplemental Content

Loading ...
Support Center